Status:
COMPLETED
Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical Sites
Lead Sponsor:
Bracco Diagnostics, Inc
Conditions:
Radiation Exposure
Eligibility:
All Genders
Brief Summary
This study is to be performed at two clinical sites where patients received CardioGen-82 during the time period January to June, 2011 and where patients were scanned chronologically near to the index ...
Detailed Description
This clinical study protocol will use a three tier approach consisting of the following examinations: * Patient examination with Survey Meter: The patient will first be tested at the clinical sites u...
Eligibility Criteria
Inclusion
- Male or female;
- Gave informed consent to participate in the study;
- Received CardioGen-82 that has been eluted from the generator in close proximity (2 days before or after) the index patients.
Exclusion
- Any patient previously enrolled in and completed this study.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT01430975
Start Date
September 1 2011
End Date
March 1 2012
Last Update
April 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bracco Diagnostics, Inc.
Princeton, New Jersey, United States, 08540